Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - A Quarterly Review of Scientific Literature on Drugs and Therapies From April -...( Novartis Takes Top Spot Previously He...)

Novartis Takes Top Spot, Previously Held by GlaxoSmithKline Since June 2006

PHILADELPHIA and LONDON, Oct. 16 /PRNewswire-FirstCall/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced the availability of its most recent quarterly review of scientific literature on drugs and therapies. "Who is Making the Biggest Splash?" was created to provide an objective assessment of how this tremendous volume of research is being received within the clinical community and to give expert measured insight into organizations that helped to shape professional opinions. In this quarterly review, Thomson Scientific has assessed the quantity and quality of the materials published by pharmaceutical companies, research institutions and other non-commercial from April - June 2007 to identify which organization has made the biggest splash.

Novartis gained pole position in this quarter's analysis, knocking GlaxoSmithKline out of the top spot for the first time since June 2006. Researchers affiliated with the firm issued 82 articles, abstracts or scientific posters between April and June 2007, more than the 73 identified in the previous quarter. The company maintained its solid Thomson Source Score of 76. Three of the other organizations at the top of the list (AstraZeneca, GlaxoSmithKline, and Eli Lilly) this quarter also ranked in the top five last quarter.

"The international pharmaceutical industry is among the most active sponsors of scientific research, so it is understandable that our findings confirm that scientific articles affiliated with, or sponsored by, pharmaceutical companies prov
'/>"/>